DrugPatentWatch Database Preview
Drugs in Development Information for Valerian
What is the drug development status for Valerian?
Valerian is an investigational drug.
There have been 8 clinical trials for Valerian.
The most recent clinical trial was a Phase 3 trial, which was initiated on September 1st 2009.
The most common disease conditions in clinical trials are Anxiety Disorders, Depressive Disorder, and Depression. The leading clinical trial sponsors are Pascoe Pharmazeutische Praeparate GmbH, Millet Roux, and Marjan Industria e Comercio ltda.
Summary for Valerian
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 3 (2009-09-01) |
| Vendors | 0 |
Recent Clinical Trials for Valerian
| Title | Sponsor | Phase |
|---|---|---|
| Therapeutic Effect of an Herbal Medicine on Anxiety | Millet Roux | Phase 3 |
| Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety | Marjan Industria e Comercio ltda | Phase 3 |
| Efficacy and Safety of St. John´s Wort/Valerian Extract Versus Placebo in Children and Adolescents With ADHD | Steiner Arzneimittel, Berlin, Germany | Phase 3 |
Clinical Trial Summary for Valerian
Top disease conditions for Valerian
Top clinical trial sponsors for Valerian
US Patents for Valerian
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
